Cerucal solution 5mg/ml 2ml #10
- 3 or more $14.49
- Availability:In Stock
Cerucal solution user manualReed more and buy Cerucal solution hereForm of release and medicinal compositionThe drug Cerucal is available in the form of tablets and a solution for injections. The solution is clear, sterile, has no..
Cerucal solution user manual
Reed more and buy Cerucal solution here
Form of release and medicinal composition
The drug Cerucal is available in the form of tablets and a solution for injections. The solution is clear, sterile, has no color and odor, is available in ampoules of transparent glass with a volume of 2 ml. Ampoules are packed in plastic pallets of 5 pieces (2) in a cardboard box, a detailed instruction describing the characteristics of the solution is attached to the preparation.
In 1 ml of the solution contains 5 mg of active ingredient - Metoclopramide hydrochloride, in 1 ampoule 10 mg of active substance. As an auxiliary component is water for injection and sodium chloride.
Indications for use
Solution Cerucal in the form of a solution for injections is intended for intravenous and intramuscular injection. The main indications for prescribing the drug are:
nausea and vomiting of various origin - associated with the use of poor-quality and stale food, diseases of the stomach, pancreas;
nausea and vomiting caused by taking certain medications;
postoperative hypotension of the stomach, resulting in a feeling of heaviness, nausea and discomfort;
paresis of the stomach against a background of severe diabetes mellitus;
the first few days after gastroduodenal sounding or endoscopy.
Contraindications for Cerucal solution
Before using the product, you should carefully read the attached instructions. Cerucal pricks are contraindicated in patients with the following cases:
individual intolerance to the components of the drug;
stenosis of the pylorus of the stomach;
intestinal obstruction or suspected of it;
age up to 2 years (for this dosage form);
pregnancy 1 trimester.
Solution for pricks Cerucal have a number of relative contraindications (when the drug can be prescribed only in extreme cases, if there are serious indications):
pregnancy 2 and 3 trimesters;
kidney and liver diseases;
A bronchial asthma or cases of a serious bronchospasm in the anamnesis;
age of the patient is more than 65 years.
Dosing and Administration
The solution Cerucal is intended for intravenous or intramuscular administration. According to the instructions, patients older than 14 years and adults are prescribed 2 ml of solution 3 times a day. Children from 2 years to 14 years of age, the dose of the drug is calculated individually, depending on the body weight and body characteristics.
The drug can be used to prevent nausea and vomiting during treatment with cytostatics in cancer patients. In this case, the solution is used for short-term and long-term drip infusions. For intravenous infusions of the solution Cerucal, an isotonic sodium chloride solution is used or a 5% solution of glucose.
With the introduction of the solution intramuscularly nothing else to dilute the contents of the ampoule is not necessary.
The duration of the course of treatment with the drug is set individually for each individual patient, depending on the indication and characteristics of the organism.
Use during pregnancy and during breastfeeding
Cerucal pricks are not prescribed for women in the first trimester of pregnancy, since there is no information on how the drug affects intrauterine development of the fetus and the experience of using this medication in obstetrics is lacking.
Use of solution for injections Cerucal women in the 2nd and 3rd trimesters of pregnancy is possible according to the indications, but only in those situations when the expected benefit for the mother exceeds the possible risks to the fetus. Treatment is carried out under the supervision of a doctor.
The appointment of pricks solution Cerucal women who breastfeed require coordination with the doctor. The drug is excreted in breast milk, so it is preferable to interrupt lactation for the duration of therapy.
During treatment with Cerucal solution, the patient may experience adverse reactions:
from the side of the nervous system - dizziness, insomnia, weakness, lethargy, apathy, unreasonable feeling of fear, anxiety, noise in the ears, twitching of the facial muscles, spasm of facial muscles, tremor of the extremities;
from the side of the cardiovascular system - changes in blood pressure (decrease or increase), tachycardia;
on the part of the digestive system - dry mouth, heartburn, belching, a feeling of heaviness in the stomach, constipation, bloating, increased gas formation;
on the part of the endocrine system - galactorrhea in women (allocation of colostrum from the breast, not associated with lactation), gynecomastia in men, menstrual cycle, violation of potency in men;
local reactions - puncture of the vein, subcutaneous hematoma, air thromboembolism, the formation of a painful infiltrate, orpinitis nausea,
With the development of one or more of the described side effects, treatment with the drug is canceled and consulted by a doctor.
If the dosage is exceeded, the patient develops overdose symptoms, which are clinically expressed as follows:
confusion of consciousness;
anxiety, drowsiness, convulsions;
disorientation in space;
increase or rapid decrease in blood pressure indicators;
When such clinical symptoms appear, treatment with the drug is immediately stopped. In most cases, all negative reactions and signs of an overdose disappear on their own 1-2 days after the abolition of therapy. In case of severe poisoning by the patient, the patient may have liver and kidney dysfunction.
Treatment of an overdose is symptomatic. The patient should be under the supervision of a doctor before stabilizing the condition.
Interaction of the drug with other drugs
The solution Cerucal is incompatible with solutions for intravenous infusion, which have an alkaline environment.
At simultaneous appointment with antibiotics, Paracetamol, Levodopa solution, Cerucal enhances the absorption of these drugs, which increases the risk of side effects and toxic damage to the liver.
Solution Cerucal in the form of injections reduces the absorption of Digoxin and Cimetidine while concomitant administration of drugs.
Under the influence of the Cerucal solution, the oppressive effect of ethanol on the central nervous system increases, as well as drugs that inhibit the rate of psychomotor reactions.
Solution Cerucal reduces the therapeutic effect of drugs from the group of H2-histaminoblockers, which should be taken into account when assigning these drugs simultaneously.
With the simultaneous administration of injections of Cerucal with hepatotoxic drugs, the risk of toxic damage to the liver increases.
During treatment with Cerucal solution, patients should refrain from driving a car and managing complex techniques that require increased concentration. This is due to possible dizziness and sluggishness of the patient on the background of therapy.
During treatment with the drug, the patient should refrain from drinking alcohol, as when combining Cerucal with alcohol, the risk of side effects from the liver and central nervous system increases.
Adolescents are more at risk of developing side effects than adult patients, so they should be under the constant supervision of specialists during treatment with Cerucal.
Patients suffering from kidney and liver disease of severe course, which are accompanied by a violation of the function of the body, the dose of the drug is calculated individually, depending on the body weight and the characteristics of the patient's body.
Cerucal solution in this dosage form can not be administered to children under 2 years of age, since there is no experience of use, and no safety has been established.
Conditions of dispensing and storage of the drug
You can buy Cerucal solution without a prescription. Ampoules with the drug should be stored out of reach of children, at a temperature of no higher than 25 degrees. Avoid direct sunlight on ampoules with solution. Shelf life of the solution is 2 years from the date of manufacture, which is indicated on the package. Do not use injectable solution with expired shelf life or if the ampoule is damaged.